How many stocks are there of Abcam?
The current number of stocks of Abcam is 226.3 M undefined.
Abcam Stocks 2024
Abcam Stocks
226.3 M
Ticker
ABC.L
ISIN
GB00B6774699
WKN
A1C605
In 2024, Abcam had 226.3 M outstanding stocks, a 0% change from the 226.3 M stocks in the previous year.
The Abcam Stocks history
| YEAR | NUMBER OF STOCKS (undefined GBP) |
|---|---|
| 2026e | 226.3 |
| 2025e | 226.3 |
| 2025e | 226.3 |
| 2024e | 226.3 |
| 2024e | 226.3 |
| 2023e | 226.3 |
| 2023e | 226.3 |
| 2022e | 226.3 |
| 2022e | 226.3 |
| 2021 | 226.3 |
| 2020 | 226 |
| 2019 | 209.6 |
| 2018 | 206.7 |
| 2017 | 205.8 |
| 2016 | 204.22 |
| 2015 | 202 |
| 2014 | 201.28 |
| 2013 | 200 |
| 2012 | 199.9 |
| 2011 | 188.5 |
| 2010 | 183.4 |
| 2009 | 182.9 |
| 2008 | 179.8 |
| 2007 | 177.9 |
| 2006 | 177.6 |
| 2005 | 165.3 |
| 2004 | 172.1 |
| 2003 | 172.1 |
| 2002 | 172.1 |
Abcam shares outstanding GB00B6774699 · A1C605
The number of shares was Abcam in 2023 — This indicates how many shares 226.3 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Abcam earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Abcam's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Abcam’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Abcam's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2002 | 172.1 M Aktien |
| 2003 | 172.1 M Aktien |
| 2004 | 172.1 M Aktien |
| 2005 | 165.3 M Aktien |
| 2006 | 177.6 M Aktien |
| 2007 | 177.9 M Aktien |
| 2008 | 179.8 M Aktien |
| 2009 | 182.9 M Aktien |
| 2010 | 183.4 M Aktien |
| 2011 | 188.5 M Aktien |
| 2012 | 199.9 M Aktien |
| 2013 | 200 M Aktien |
| 2014 | 201.28 M Aktien |
| 2015 | 202 M Aktien |
| 2016 | 204.22 M Aktien |
| 2017 | 205.8 M Aktien |
| 2018 | 206.7 M Aktien |
| 2019 | 209.6 M Aktien |
| 2020 | 226 M Aktien |
| 2021 | 226.3 M Aktien |
| 2022e | 226.3 M Aktien |
| 2022e | 226.3 M Aktien |
| 2023e | 226.3 M Aktien |
| 2023e | 226.3 M Aktien |
| 2024e | 226.3 M Aktien |
| 2024e | 226.3 M Aktien |
| 2025e | 226.3 M Aktien |
| 2025e | 226.3 M Aktien |
| 2026e | 226.3 M Aktien |
Abcam Aktienanalyse
What does Abcam do?
Abcam PLC is an internationally operating company specializing in the development, manufacturing, and distribution of antibodies and other reagents for life science research. History: Abcam was founded in 1998 by Jonathan Milner, a biologist and cancer researcher who had experienced using antibodies in research. Recognizing a need for high-quality and reliable reagents in this field, he decided to start his own company. In the years following its founding, Abcam grew rapidly and established itself as one of the leading providers of antibodies. In 2005, the company went public on the London Stock Exchange, raising capital for further expansion. Since then, Abcam has made numerous acquisitions and expanded its product portfolio. Business model: Abcam's business model is based on selling antibodies and other reagents to research institutions, universities, and pharmaceutical companies. The company relies on an extensive network of suppliers and partners to offer a wide range of products. Another important aspect of the business model is the online marketing of Abcam's products. The company operates several websites where customers can browse and order the entire product range. To better understand customer needs, Abcam also conducts regular customer surveys and feedback. Divisions: Abcam offers a wide range of products and services, which are grouped into various divisions: Antibodies: The antibodies division is Abcam's core area, encompassing a variety of monoclonal and polyclonal antibodies for various applications. Proteins: Abcam also offers a wide range of proteins for research in areas such as cancer, neurology, and metabolic diseases. Reagents: In addition to antibodies and proteins, Abcam provides a variety of reagents, including kits for biomarker or enzyme activity determination. Services: Abcam also offers a range of services, including custom antibody development, protein expression, and assay development. Products: Abcam offers a wide range of products for use in various areas of life science research. Some of the most well-known products include: Rabbit monoclonal antibodies: These antibodies are highly specific and sensitive, making them valuable tools in cancer research. Chromatin & nucleic acid purification kits: These kits enable efficient purification of DNA, RNA, and chromatin, which is essential for many genomic and epigenomic applications. ELISA kits: Abcam offers a variety of ELISA kits for the determination of biomarkers and other target molecules. Overall, Abcam is a leading provider of antibodies and other reagents for life science research. Through constant innovation and expansion, the company has successfully grown its business in recent years and is now well-positioned worldwide. Abcam ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Abcam's Shares Outstanding
Abcam's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Abcam’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Abcam’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Abcam’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Abcam stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Abcam are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Abcam evolved in recent years?
The number of shares of Abcam has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Abcam as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Abcam?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Abcam pay?
Over the past 12 months, Abcam paid a dividend of 0.04 GBP . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Abcam is expected to pay a dividend of 0.49 GBP.
What is the dividend yield of Abcam?
The current dividend yield of Abcam is 0.29 %.
When does Abcam pay dividends?
Abcam pays a quarterly dividend. This is distributed in the months of December, April, December, April.
How secure is the dividend of Abcam?
Abcam paid dividends every year for the past 4 years.
What is the dividend of Abcam?
For the upcoming 12 months, dividends amounting to 0.49 GBP are expected. This corresponds to a dividend yield of 4 %.
In which sector is Abcam located?
Abcam is assigned to the 'Health' sector.
Wann musste ich die Aktien von Abcam kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Abcam from 4/17/2020 amounting to 0.036 GBP, you needed to have the stock in your portfolio before the ex-date on 3/19/2020.
When did Abcam pay the last dividend?
The last dividend was paid out on 4/17/2020.
What was the dividend of Abcam in the year 2023?
In the year 2023, Abcam distributed 0 GBP as dividends.
In which currency does Abcam pay out the dividend?
The dividends of Abcam are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Abcam stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Abcam
Our stock analysis for Abcam Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abcam Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
